ArticleLeukemia2024

Molecular relapse after first-line intensive therapy in patients with CBF or NPM1-mutated acute myeloid leukemia - a FILO study.

Corentin Orvain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.